Tower Research Capital LLC (TRC) - HILLSTREAM BIOPHARMA INC ownership

HILLSTREAM BIOPHARMA INC's ticker is and the CUSIP is 432705101. A total of 9 filers reported holding HILLSTREAM BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of HILLSTREAM BIOPHARMA INC
ValueSharesWeighting
Q3 2023$3,813
-40.1%
19,067
+9.4%
0.00%
Q2 2023$6,361
+70577.8%
17,427
+47.3%
0.00%
Q1 2023$9
+125.0%
11,828
+30.7%
0.00%
Q4 2022$4
-99.9%
9,050
+6.1%
0.00%
Q3 2022$7,000
+75.0%
8,531
+85.3%
0.00%
Q2 2022$4,000
-69.2%
4,605
-43.2%
0.00%
Q1 2022$13,0008,1110.00%
Other shareholders
HILLSTREAM BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 16,422$13,0000.00%
Renaissance Technologies 11,400$9,0000.00%
WELLS FARGO & COMPANY/MN 26$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 29,515$23,0000.00%
MORGAN STANLEY 3,405$3,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 26,596$21,0000.00%
HRT FINANCIAL LP 20,659$16,0000.00%
Tower Research Capital LLC (TRC) 4,605$4,0000.00%
View complete list of HILLSTREAM BIOPHARMA INC shareholders